A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

NCT07300969 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: DT-101
DRUG: DT-101
DRUG: Placebo

Sponsor

Draig Therapeutics Ltd